Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Semyon Churbanov"'
Autor:
Alexey Fayzullin, Semyon Churbanov, Natalia Ignatieva, Olga Zakharkina, Mark Tokarev, Daniil Mudryak, Yana Khristidis, Maxim Balyasin, Alexandr Kurkov, Elena N. Golubeva, Nadejda A. Aksenova, Tatyana Dyuzheva, Peter Timashev, Anna Guller, Anatoly Shekhter
Publikováno v:
Biomedicines, Vol 9, Iss 8, p 853 (2021)
Peri-implant fibrosis (PIF) increases the postsurgical risks after implantation and limits the efficacy of the implantable drug delivery systems (IDDS). Pirfenidone (PF) is an oral anti-fibrotic drug with a short (0) and PLA0 with an equivalent singl
Externí odkaz:
https://doaj.org/article/df8adf73150d4159ac7d0bc5c1de1696
Autor:
Alexey Fayzullin, Natalia Ignatieva, Olga Zakharkina, Mark Tokarev, Daniil Mudryak, Yana Khristidis, Maxim Balyasin, Alexandr Kurkov, Semyon Churbanov, Tatyana Dyuzheva, Peter Timashev, Anna Guller, Anatoly Shekhter
Publikováno v:
Biology, Vol 10, Iss 2, p 136 (2021)
Mature hypertrophic scars (HSs) remain a challenging clinical problem, particularly due to the absence of biologically relevant experimental models as a standard rabbit ear HS model only reflects an early stage of scarring. The current study aims to
Externí odkaz:
https://doaj.org/article/28d18172c49c4a3b84977d0a00bd7475
Autor:
Alexandra Igrunkova, Alexey Fayzullin, Semyon Churbanov, Polina Shevchenko, Natalia Serejnikova, Natalia Chepelova, Dmitry Pahomov, Ekaterina Blinova, Karen Mikaelyan, Victoria Zaborova, Konstantin Gurevich, Aleksandr Urakov, Anatoly Vanin, Peter Timashev, Anatoly Shekhter
Publikováno v:
Drug Design, Development and Therapy.
Alexandra Igrunkova,1,2 Alexey Fayzullin,1,2 Semyon Churbanov,1 Polina Shevchenko,1 Natalia Serejnikova,1,2 Natalia Chepelova,1,2 Dmitry Pahomov,3 Ekaterina Blinova,4 Karen Mikaelyan,1 Victoria Zaborova,5,6 Konstantin Gurevich,7 Aleksandr Urakov,8,9
Autor:
Andrea De Pieri, Stefanie H. Korntner, Hector Capella-Monsonis, Dimitrios Tsiapalis, Sergei V. Kostjuk, Semyon Churbanov, Peter Timashev, Alexander Gorelov, Yuri Rochev, Dimitrios I. Zeugolis
Publikováno v:
Biomaterials. 287
Scaffold-free in vitro organogenesis exploits the innate ability of cells to synthesise and deposit their own extracellular matrix to fabricate tissue-like assemblies. Unfortunately, cell-assembled tissue engineered concepts require prolonged ex vivo